4.8 Article

Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCC

Journal

FRONTIERS IN IMMUNOLOGY
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.03095

Keywords

squamous; carcinoma; metastasis; myeloid; suppressor

Categories

Funding

  1. National Cancer Institute (NIH/NCI) [K01CA207599]
  2. National Center for Advancing Translational Sciences (NIH/NCATS) [UL1TR001070]
  3. American Cancer Society (ACS) [RSG-19-079-01-TBG]

Ask authors/readers for more resources

Head and neck squamous cell carcinoma (HNSCC) is a prevalent form of cancer with 5-years survival rates around 57%, and metastasis is a leading cause of mortality. Host-derived immunological factors that affect HNSCC tumor development and metastasis are not completely understood. We investigated the role of host-derived signal transducer and activator of transcription 4 (STAT4) during experimental HNSCC using an aggressive and metastatic HNSCC cell line, LY2, which was orthotopically injected into the buccal sulcus of wild type (WT) and STAT4 deficient (Stat4(-/-)) BALB/c mice. Necropsies performed at terminal sacrifice revealed that Stat4(-/-) mice displayed comparable primary tumor growth to the WT mice. However, the rate and extent of lymph node and lung metastasis among Stat4(-/-) mice was significantly higher. Downstream analyses performed on primary tumors, draining lymph nodes, spleens and bone marrow revealed significant upregulation of lymphocytic immunosuppressive biomarkers as well as an accumulation of granulocytic MDSC subpopulations in draining lymph nodes of metastatic Stat4(-/-) mice. Further, we observed a significant decrease in T(H)1, T(H)17, and cytotoxic activity in tumor bearing Stat4(-/-) compared to WT mice. Our results demonstrate that STAT4 mediates resistance to HNSCC metastasis, and activation of STAT4 could potentially mitigate lymphatic metastasis in HNSCC patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis

Thalia Pacheco-Fernandez, Greta Volpedo, Chaitenya Verma, Abhay R. Satoskar

Summary: Leishmaniasis is a neglected tropical disease transmitted by sand flies and manifests clinically in various forms. Host immune responses are critical in fighting against the disease, but Leishmania parasites manipulate these responses for their own survival. Factors like sand fly salivary proteins and microbiota also influence disease susceptibility.

BIOCHEMICAL SOCIETY TRANSACTIONS (2021)

Article Cell Biology

Effect of Short-Term Tacrolimus Exposure on Rat Liver: An Insight into Serum Antioxidant Status, Liver Lipid Peroxidation, and Inflammation

N. Fatima, N. Sheikh, A. R. Satoskar, T. Akhtar, A. Tayyeb, I Ashfaq, N. Ryan, S. Ambreen, B. K. Jha, S. Oghumu

Summary: The study revealed that even short-term exposure to tacrolimus (TAC) can induce changes in antioxidant status and lipid peroxidation in the liver of rats, leading to significant alterations in liver structure and increased inflammatory response.

MEDIATORS OF INFLAMMATION (2021)

Article Oncology

Inhibition of PI3K Isoform p110γ Increases Both Anti-Tumor and Immunosuppressive Responses to Aggressive Murine Head and Neck Squamous Cell Carcinoma with Low Immunogenicity

Kelvin Anderson, Nathan Ryan, Anastasia Alkhimovitch, Arham Siddiqui, Steve Oghumu

Summary: Inhibition of PI3K p110 gamma may enhance the anti-tumor immune response against poorly immunogenic HNSCC, particularly when used in combination with selective checkpoint inhibitors.

CANCERS (2021)

Review Immunology

Revival of Leishmanization and Leishmanin

Thalia Pacheco-Fernandez, Greta Volpedo, Sreenivas Gannavaram, Parna Bhattacharya, Ranadhir Dey, Abhay Satoskar, Greg Matlashewski, Hira L. Nakhasi

Summary: Leishmaniasis is a disease caused by parasitic protozoa transmitted by infected sandflies, affecting over 1 billion people worldwide. The successful vaccination procedure known as leishmanization, which has been used in the Middle East for decades, is no longer practiced due to safety and ethical concerns. New genome editing technologies may allow for the development of a second generation leishmanization that could enter human trials.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Parasitology

Molecular characterization and genetic diversity of cutaneous leishmaniasis from North Eastern Pakistan

Nargis Shaheen, Chaitenya Verma, Thalia Pacheco-Fernandez, Greta Volpedo, Aneeqa Hamid, Ismail Zeb, Syed Aizaz Ali Shah, Shah Fahad, Attiya Iqbal, Asma Ashraf, Amjad Khan, Misbah Gul, Muhammad Ilyas Khan, Huma Fatima, Muhammad Afzal, Abhay R. Satoskar, Naveeda Akhter Qureshi

Summary: This study aimed to elucidate the molecular characterization and genetic diversity of Leishmania spp. in North Eastern Pakistan. The findings confirmed the presence of Leishmania tropica, Leishmania major, and Leishmania infantum, with Leishmania tropica showing significantly higher nucleotide variation. Recommendations for more extensive investigations to understand the molecular epidemiology of Leishmania in the region were made.

ACTA TROPICA (2021)

Review Immunology

From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection

Greta Volpedo, Ryan H. Huston, Erin A. Holcomb, Thalia Pacheco-Fernandez, Sreenivas Gannavaram, Parna Bhattacharya, Hira L. Nakhasi, Abhay R. Satoskar

Summary: Leishmaniasis is a significant public health issue globally, requiring effective vaccines for prevention and control. The disease leads to long-term disabilities, psycho-sociological trauma, poverty, and gender disparity. Challenges in research include manufacturing vaccines, conducting clinical trials, and defining correlates of protection.

EXPERT REVIEW OF VACCINES (2021)

Review Immunology

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)

Greta Volpedo, Thalia Pacheco-Fernandez, Erin A. Holcomb, Natalie Cipriano, Blake Cox, Abhay R. Satoskar

Summary: Leishmaniasis is a neglected tropical disease affecting 12 million people worldwide. Cutaneous leishmaniasis (CL) is the most common form, presenting as ulcerating skin lesions that can self-heal or become chronic. The balance of immune response and inflammatory mediators plays a vital role in the clinical presentation and outcome of the disease.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Biology

Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis

Subir Karmakar, Nevien Ismail, Fabiano Oliveira, James Oristian, Wen Wei Zhang, Swarnendu Kaviraj, Kamaleshwar P. Singh, Abhishek Mondal, Sushmita Das, Krishna Pandey, Parna Bhattacharya, Greta Volpedo, Sreenivas Gannavaram, Monika Satoskar, Sanika Satoskar, Rajiv M. Sastry, Claudio Meneses, Shinjiro Hamano, Pradeep Das, Greg Matlashewski, Sanjay Singh, Shaden Kamhawi, Ranadhir Dey, Jesus G. Valenzuela, Abhay Satoskar, Hira L. Nakhasi

Summary: Karmakar et al. developed a dermotropic, live attenuated centrin gene-deleted Leishmania major (LmCen(-/-)) vaccine against Visceral Leishmaniasis (VL), demonstrating that a single intradermal injection provides robust and durable protection against lethal VL transmitted through sand fly bites.

COMMUNICATIONS BIOLOGY (2021)

Review Immunology

Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development

Greta Volpedo, Thalia Pacheco-Fernandez, Parna Bhattacharya, Timur Oljuskin, Ranadhir Dey, Sreenivas Gannavaram, Abhay R. Satoskar, Hira L. Nakhasi

Summary: Leishmaniasis is a disease endemic in tropical and subtropical regions transmitted by infected sand flies. The interactions between Leishmania, host immune cells, and adaptive immunity play a crucial role in disease severity and development. Besides cytokine signals, metabolic shifts in innate cells also influence immune signaling cascades in Leishmania pathogenesis.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis

Greta Volpedo, Thalia Pacheco-Fernandez, Erin A. Holcomb, Wen-Wei Zhang, Patrick Lypaczewski, Blake Cox, Rebecca Fultz, Chelsea Mishan, Chaitenya Verma, Ryan H. Huston, Abigail R. Wharton, Ranadhir Dey, Subir Karmakar, Steve Oghumu, Shinjiro Hamano, Sreenivas Gannavaram, Hira L. Nakhasi, Greg Matlashewski, Abhay R. Satoskar

Summary: Using the CRISPR/Cas9 technique, researchers have successfully generated live attenuated centrin knockout L. mexicana parasites. These parasites exhibit a growth defect and lower parasitic burdens compared to the wild type, as well as increased production of protective cytokines. In pre-clinical models, immunization with the LmexCen(-/-) parasites is safe and efficacious, leading to protective immunity and reduced parasitic burdens at the infection site and draining lymph nodes.

NPJ VACCINES (2022)

Review Microbiology

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates

Greta Volpedo, Parna Bhattacharya, Sreenivas Gannavaram, Thalia Pacheco-Fernandez, Timur Oljuskin, Ranadhir Dey, Abhay R. Satoskar, Hira L. Nakhasi

Summary: Leishmaniasis is a neglected tropical disease that affects millions of people worldwide. Current treatments are not highly effective and have high costs and toxicity. The development of a prophylactic vaccine has become a high priority, but the ability of Leishmania to undermine immune recognition has hindered progress. Live attenuated Leishmania parasites that provide a complete range of antigens could be effective vaccine candidates. This review focuses on the development of live attenuated Leishmania vaccines and discusses the challenges of transitioning from the laboratory to human clinical trials.

PATHOGENS (2022)

Article Biotechnology & Applied Microbiology

Inducible TgfbR1 and Pten deletion in a model of tongue carcinogenesis and chemoprevention

Felipe F. F. Lamenza, Nathan M. M. Ryan, Puja Upadhaya, Arham Siddiqui, Pete P. P. Jordanides, Anna Springer, Peyton Roth, Hasan Pracha, O. Hans Iwenofu, Steve Oghumu

Summary: Head and neck squamous cell carcinoma (HNSCC) is a significant public health problem. We optimized a mouse model of tongue carcinogenesis and found that dietary administration of black raspberries can reduce tumor growth and enhance anti-tumor activity.

CANCER GENE THERAPY (2023)

Article Immunology

Development of a novel immunoFET technology-based POC assay for detection of Leishmania donovani and Leishmania major

Nebiye Yentur Doni, Paul J. Bertani, Greta Volpedo, Noushin Saljoughian, Sanjay Varikuti, Greg Matlashewski, Wu Lu, Abhay R. Satoskar

Summary: This article introduces the use of immuno field effect transistors (ImmunoFET) biosensors for monitoring and detecting Leishmania parasites. The current methods of leishmanial diagnosis are time-consuming, costly, and require special equipment and trained personnel. The study demonstrates that ImmunoFET biosensors can successfully detect the presence of Leishmania parasites and have the potential to provide earlier and faster detection of leishmaniasis compared to ELISA.

PARASITE IMMUNOLOGY (2023)

Article Oncology

Ionizing Radiation Reduces Head and Neck Squamous Cell Carcinoma Cell Viability and Is Associated with Predictive Tumor-Specific T Cell Responses

Puja Upadhaya, Nathan Ryan, Peyton Roth, Travis Pero, Felipe Lamenza, Anna Springer, Pete Jordanides, Hasan Pracha, Darrion Mitchell, Steve Oghumu

Summary: This study demonstrates that tumor-targeted radiation therapy can generate tumor antigens that induce strong immune responses. These responses show comparable sensitivity but greater specificity for T cell activation compared to conventional antibodies. This information can be utilized to predict patient responses to radiation and immune therapy.

CANCERS (2023)

Meeting Abstract Public, Environmental & Occupational Health

EVALUATION OF SAFETY AND EFFICACY OF NEW WORLD LEISHMANIA MEXICANA CENTRIN GENE DELETED (LMEXCEN-/-) LIVE ATTENUATED PARASITES AS A PROPHYLACTIC VACCINE AGAINST VISCERAL LEISHMANIASIS

Subir Karmakar, Nevien Ismail, Wenwei Zhang, Oliveira Fabiano, Greta Volpedo, Shinjiro Hamano, Greg Matlashewski, Shaden Kamhawi, Jesus Valenzuela, Abhay Satoskar, Ranadhir Dey, Hira Nakhasi

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)

No Data Available